Biotech Values

[DewDiligence]

Don and I announced our positions in XOMA last week (#msg-82929844, #msg-82928612, #msg-82929413). With new management, new financing, and a new business plan, XOMA is clearly a different company from the one many of us despised in the past. This doesn’t ensure success, of course, but it gives XOMA a favorable benefit/risk tradeoff for the first time in a long time.